Makoto Ota
Founder at WELBE, INC.
Net worth: 38 M $ as of 2024-04-29
Makoto Ota active positions
| Companies | Position | Start | End |
|---|---|---|---|
| WELBE, INC. | Director/Board Member | 2011-11-30 | - |
| Founder | 2011-11-30 | - | |
| President | 2011-11-30 | - | |
| Welbe Healthcare, Inc. | Director/Board Member | 2021-05-31 | - |
Career history of Makoto Ota
Former positions of Makoto Ota
| Companies | Position | Start | End |
|---|---|---|---|
| TELLA, INC. | Director/Board Member | 2004-10-31 | - |
Statistics
International
| Japan | 3 |
| 2 |
Operational
| Director/Board Member | 3 |
| Founder | 1 |
| President | 1 |
Sectoral
| Health Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
| Welbe, Inc. | |
| Welbe Healthcare, Inc. | Health Services |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Makoto Ota
- Experience
